Kura Oncology, Inc. (KURA)

Paramount Global Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-197.17	-173.98	-152.63	-135.84	-130.47	-89.63
Depreciation & Amortization	0.88	0.85	0.85	0.76	0.56	0.19
Loss (Gain) From Sale of Investments	-11.5	-13.14	-9.42	1.61	4.39	0.41
Stock-Based Compensation	31.75	33.9	28.08	26.32	23.58	12.81
Other Operating Activities	0.55	0.52	0.48	0.07	0.61	-
Change in Accounts Receivable	-2.51	-	-	-	-	-
Change in Accounts Payable	20.48	15.2	10.33	-0.8	-2.52	5.68
Change in Unearned Revenue	301.94	278.18	-	-	-	-
Change in Other Net Operating Assets	-19.41	-7.21	-2.51	-2.18	-0.71	0.71
Operating Cash Flow	124.99	134.32	-124.82	-110.06	-104.55	-69.83
Capital Expenditures	-2.12	-0.47	-0.17	-0.63	-1.15	-2.17
Investment in Securities	-89.77	-101.12	15.73	33.25	-125.69	-97.77
Investing Cash Flow	-91.89	-101.59	15.56	32.63	-126.84	-99.94
Long-Term Debt Issued	-	-	-	10	-	-
Total Debt Issued	-	-	-	10	-	-
Long-Term Debt Repaid	-	-	-	-	-7.25	-0.25
Net Debt Issued (Repaid)	-	-	-	10	-7.25	-0.25
Issuance of Common Stock	3.67	154.42	94.78	29.14	4.43	469.58
Other Financing Activities	-	-	-	-0.58	-0.61	-
Financing Cash Flow	3.67	154.42	94.78	38.57	-3.44	469.33
Net Cash Flow	36.77	187.14	-14.48	-38.87	-234.82	299.57
Free Cash Flow	122.87	133.85	-124.99	-110.69	-105.7	-72
Free Cash Flow Margin	147.53%	248.40%	-	-	-	-
Free Cash Flow Per Share	1.41	1.55	-1.71	-1.65	-1.59	-1.36
Cash Interest Paid	1.1	1.1	1.06	0.07	0.78	0.42
Levered Free Cash Flow	-57.68	-55.93	-63.9	-63.67	-60.41	-42.36
Unlevered Free Cash Flow	-56.68	-54.92	-62.93	-63.53	-60.15	-41.99
Change in Working Capital	300.5	286.17	7.82	-2.98	-3.22	6.38

Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q